REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

SSY Group Limited (石四药集团有限公司) (Hong Kong SAR, China)

Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Full name: SSY Group Limited Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

SSY Group Limited (石四药集团有限公司) is an enterprise in Hong Kong SAR, China, with the main office in Hong Kong. The enterprise currently operates in the Chemical Manufacturing sector. The enterprise was incorporated on September 28, 2004. It currently has a total number of 6,100 (2024) employees. The latest financial highlights indicate a net sales revenue drop of 35.69% in Q2C2025. Its total assets grew by 1.94% over the same period. The net profit margin of SSY Group Limited (石四药集团有限公司) decreased by 7.38% in 2025.

Headquarters
Rooms 4902-03, 49Th Floor, Central Plaza, 18 Harbour Road, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the SSY Group Limited (石四药集团有限公司) report to view the information.

Website: http://www.ssygroup.com.hk

Basic Information
Total Employees:
Purchase the SSY Group Limited (石四药集团有限公司) report to view the information.
Outstanding Shares:
Purchase the SSY Group Limited (石四药集团有限公司) report to view the information.
Registered Capital:
Purchase the SSY Group Limited (石四药集团有限公司) report to view the information.
Financial Auditors:
Purchase the SSY Group Limited (石四药集团有限公司) report to view the information.
Incorporation Date:
September 28, 2004
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
28.9%
Purchase this report to view the information.
15.11%
Purchase this report to view the information.
9.78%
Purchase this report to view the information.
6.15%
Subsidiaries
New Orient Investments Pharmaceutical Holding (Hong Kong) Limited (United Kingdom)
100%
Jiangsu Best New Medical Material Co., Ltd. (China)
39%
Company Performance
Financial values in the chart are available after SSY Group Limited (石四药集团有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-35.69%▼
Total Operating Revenue
-33.62%▼
Operating Profit
-55.7%▼
EBITDA
-45.08%▼
Net Profit/Loss for the Period
-58.41%▼
Total Assets
1.94%▲
Total Equity
0.37%▲
Operating Profit Margin
-8.04%▼
Net Profit Margin
-7.38%▼
Return on Equity (ROE)
-5.4%▼
Debt / Equity
5172%▲
Quick Ratio
339.54%▲
Cash Ratio
0.04%▲

Similar companies

China Resources Pharmaceutical Group Ltd
 
Fosun International Limited
Kingboard Holdings Limited
 
CSPC Pharmaceutical Group Limited
Sino Biopharmaceutical Limited
 
Fufeng Group Limited
HUTCHMED China Limited
 
Lam Soon Hong Kong Limited
China Shineway Pharmaceutical Group Limited
 
GHW International (Nanjing) (GHW International (南京))
Lee & Man Chemical Company Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo